Identification of mutations in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects

Journal of Medical Genetics

Volumn 39, Issue 4, 2002, Pages 271-275

  Muller, P Y ^a   Miserez, Andre R ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

STEROL REGULATORY ELEMENT BINDING PROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0036251719     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.39.4.271     Document Type: Article

References (38)

1. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
2. A receptor-mediated pathway for cholesterol homeostasis
3. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100
4. The role of apolipoprotein E genetic variants in lipoprotein disorders
5. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
6. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
7. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element
8. Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection
9. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells
10. Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies
11. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs
12. Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2)
13. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
14. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver
15. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene
16. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia
17. Blood lipids in the Swiss population: MONICA study 1988-89
18. Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations
19. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
20. Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions
21. Gene probes in diagnosis of familial hypercholesterolemia
22. Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with Mspl
23. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
24. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia
25. High prevalence of familial defective apolipoprotein B-100 in Switzerland
26. Multiple sequence alignment with hierarchical clustering
27. Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia
28. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred
29. A third major locus for autosomal dominant hypercholesterolemia maps to 1 p34, 1-p32
30. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations
31. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants
32. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study
33. The effects of the apolipoprotein B signal peptide (ins/del) and Xbal polymorphisms on plasma lipid responses to dietary change
34. The power of point mutations
35. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
36. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping
37. Sterol regulatory element-binding proteins: Activators of choresterol and fatty acid biosynthesis